⌘K
Skytech Infinite Platform Limited was originally incorporated as a Private Limited Company on May 28, 2009, and later converted into a Public Limited Company. The company's business description primarily details its incorporation history rather than its operational activities.
Deterministic verdict 'Neutral': listing=55/Neutral, short=68/Neutral Positive, long=54/Neutral; overall=55.8; confidence=95.5/100 | computed financials: fin=82, growth=78, D/E=0.49 (70% math / 30% model) | market signals: alignment=n/a (OFS None%), anchor quality=n/a (marquee None%), GMP trend=stable, overhang=n/a | demand profile: reservation weights QIB/NII/Ret 1%/49%/50%, QIB effective demand=0.01x, institutional contribution=1%, breadth=0.42 | red flags: R5_litigation (litigation disclosed (advisory, not a specific severe matter)) | rule: mixed signals -> Neutral. | Analyst notes: Skytech Infinite Platform SME IPO presents a mixed bag. The company demonstrates strong financial performance with robust PAT and EBITDA growth, healthy margins, and impressive return ratios (ROCE, RoNW). The valuation appears highly attractive with a post-IPO P/E of 17.99x, P/B of 1.19x, and EV/EBITDA of 4.8x. However, these positives are significantly overshadowed by critical business and governance concerns. The business model is vaguely described, with no clear products or services, and there's a concerning disconnect between the company's description and the industry's addressable market. High customer and supplier concentration pose substantial operational risks. Furthermore, regulatory non-compliance, including delayed statutory filings and issues with approvals, raises serious governance red flags. The company has also reported negative cash flows and increasing debt. Market sentiment is notably weak, reflected in a low GMP and poor institutional (QIB and NII) subscription. While the financials and valuation are compelling, the profound lack of business clarity, significant operational risks, and governance issues make this a high-risk proposition. The strong financials might be masking underlying operational fragilities. Therefore, a 'Risky Apply' verdict is assigned, suitable only for investors with a high-risk appetite willing to overlook significant qualitative concerns for potential valuation upside.
Listing-day performance is not available yet. It will appear here once this IPO has listed and results are recorded.
| Category | Shares Offered | % of Issue | Share |
|---|---|---|---|
| QIB | 28,800 | 0.98% | |
| NII (HNI) | 13,72,800 | 46.61% | |
| Retail | 13,95,200 | 47.37% | |
| Market Maker | 1,48,800 | 5.05% |
Premium gain of 1.3% over issue price.
Strong PAT and EBITDA growth over recent fiscals.
Healthy EBITDA and PAT margins.
Robust return ratios (ROCE and RoNW > 20%).
Attractive post-IPO P/E (17.99x), P/B (1.19x), and EV/EBITDA (4.8x) based on FY26 financials.
High promoter holding post-IPO (70.01%).
Consistent revenue growth.
Successful diversification of customer and supplier base, resolution of regulatory issues, and effective deployment of IPO proceeds for growth initiatives.
Continued organic growth in existing customer segments, stable market conditions, and gradual improvement in operational efficiencies.
Loss of key customers or suppliers, failure to address regulatory non-compliance, sustained negative cash flows, or increased competition impacting margins.
The current GMP is very low (1.3% premium), and institutional subscription (QIB, NII) was weak, indicating limited demand for listing gains despite attractive valuation multiples.
Significant business and governance risks, coupled with weak market sentiment and negative cash flows, make it a risky short-term investment. The attractive valuation might not hold if these risks materialize.
While the company shows strong profit growth and attractive valuation, the fundamental lack of business clarity, high concentration risks, and governance issues pose substantial long-term uncertainties. Suitable only for high-risk tolerant investors who believe these issues can be resolved.
Final verdict: Neutral (confidence High).
Positive: Strong PAT and EBITDA growth over recent fiscals.
Concern: Vague business description and lack of clear product/service details.
Advisory: litigation disclosed (advisory, not a specific severe matter)
Listing-gain vs long-term: Neutral / Neutral.